Lota S. Zoth, Director of enGene Therapeutics ENGN, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/16.

LZ

LZ

Lota S. Zoth

Director

Company

enGene Therapeutics ENGN

First filing

23/02/13

Trades

37 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Inovio PharmaceuticalsINO	Open-market sale	23/06/05	23/06/05	5,700 sh	$0.56	$3,192	−9.8%